|Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association|
AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, WB Borden, ...
circulation 127 (1), 143-152, 2013
|Heart disease and stroke statistics-2017 update: a report from the American Heart Association.|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, J Floyd, ...
Circulation 135 (10), e146-e603, 2017
|Apixaban versus warfarin in patients with atrial fibrillation|
CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ...
New England Journal of Medicine 365 (11), 981-992, 2011
|2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed …|
Authors/Task Force Members, AJ Camm, GYH Lip, R De Caterina, ...
European heart journal 33 (21), 2719-2747, 2012
|American heart association statistics committee and stroke statistics subcommittee|
EJ Benjamin, MJ Blaha, SE Chiuve, M Cushman, SR Das, R Deo, ...
Heart disease and stroke statistics-2017 update: a report from the American …, 2017
|Apixaban with antiplatelet therapy after acute coronary syndrome|
JH Alexander, RD Lopes, S James, R Kilaru, Y He, P Mohan, DL Bhatt, ...
New England Journal of Medicine, 2011
|Thrombin-receptor antagonist vorapaxar in acute coronary syndromes|
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
|Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial|
SH Hohnloser, Z Hijazi, L Thomas, JH Alexander, J Amerena, M Hanna, ...
European heart journal 33 (22), 2821-2830, 2012
|Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale|
RD Lopes, JH Alexander, SM Al-Khatib, J Ansell, R Diaz, JD Easton, ...
American heart journal 159 (3), 331-339, 2010
|Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo …|
PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ...
The Lancet 390 (10105), 1833-1842, 2017
|CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial …|
AJ Camm, GY Lip, R De Caterina, I Savelieva, D Atar, SH Hohnloser, ...
Europace 14 (10), 1385-1413, 2012
|Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery|
RD Lopes, GE Hafley, KB Allen, TB Ferguson, ED Peterson, ...
New England Journal of Medicine 361 (3), 235-244, 2009
|Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCLINICAL PERSPECTIVE|
JP Piccini, RD Lopes, MH Kong, V Hasselblad, K Jackson, SM Al-Khatib
Circulation: Arrhythmia and Electrophysiology 2 (6), 626-633, 2009
|Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial|
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
|Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in …|
EM Hylek, C Held, JH Alexander, RD Lopes, R De Caterina, DM Wojdyla, ...
Journal of the American College of Cardiology 63 (20), 2141-2147, 2014
|Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women's Health Initiative|
AK Chomistek, JAE Manson, ML Stefanick, B Lu, M Sands-Lincoln, ...
Journal of the American College of Cardiology 61 (23), 2346-2354, 2013
|Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial|
JD Easton, RD Lopes, MC Bahit, DM Wojdyla, CB Granger, L Wallentin, ...
The Lancet Neurology, 2012
|Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other …|
G Flaker, RD Lopes, SM Al-Khatib, AG Hermosillo, SH Hohnloser, B Tinga, ...
Journal of the American College of Cardiology 63 (11), 1082-1087, 2014
|Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention|
RH Mehta, AZ Starr, RD Lopes, JS Hochman, P Widimsky, KS Pieper, ...
JAMA 301 (17), 1779-1789, 2009
|Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial|
S Halvorsen, D Atar, H Yang, R De Caterina, C Erol, D Garcia, ...
European heart journal 35 (28), 1864-1872, 2014